DNA Methylation Study Reveals Inflammation Drives Abdominal Aortic Aneurysm Risk
The largest epigenome-wide study of AAA identifies 1,253 methylation markers and points to inflammatory and lipid pathways as key causal drivers.
Summary
Researchers used the VA Million Veteran Program — over 43,000 participants — to conduct the largest epigenome-wide association study of abdominal aortic aneurysm (AAA) to date. They identified 1,253 DNA methylation sites linked to AAA risk, with Mendelian randomization supporting a causal role for 143 of them. Functional analysis revealed that inflammatory transcription factors — particularly activator protein-1 and NF-κB — sit at the center of the disease architecture. Blood lipids mediated a large share of the risk near cholesterol-related genes, while circulating proteins including MMP9 and IL1RN emerged as inflammation-linked intermediates. The team also built a methylation risk score that predicted AAA risk even after accounting for traditional clinical factors. These findings open new avenues for early detection and potential therapeutic targeting of epigenetic and inflammatory mechanisms underlying this deadly vascular condition.
Detailed Summary
Abdominal aortic aneurysm (AAA) is a life-threatening vascular condition whose epigenetic underpinnings have remained largely unexplored. Understanding which DNA methylation changes are causally linked to AAA — rather than merely associated — could unlock both better biomarkers and new treatment targets. This study represents a major step in that direction.
Using the VA Million Veteran Program, researchers performed an epigenome-wide association study comparing 1,324 incident AAA cases against 42,065 controls. They then applied Mendelian randomization to distinguish causal methylation signals from confounding, conducted stratified analyses by population group and smoking status, and used expression quantitative trait methylation analyses to connect CpG sites to gene expression in blood, aorta, and liver tissue.
The study identified 1,253 CpG methylation sites associated with AAA, with Mendelian randomization supporting causal inference for 143. Functional annotation showed these sites cluster primarily at distal enhancers enriched for activator protein-1 (AP-1) and NF-κB transcription factor binding — both master regulators of inflammation. Network Mendelian randomization mapped 135 putative causal pathways, including 77 through inflammation-related traits. Key inflammatory mediators included MMP9, MMP13, IL1RN, DAG1, and NEXN. Blood lipid traits mediated more than 40% of associations near LDLR and TRIB1, linking cholesterol biology to epigenetic AAA risk. A methylation risk score built from selected CpGs outperformed clinical risk models and validated in two independent cohorts.
For longevity-focused clinicians and researchers, these findings reinforce inflammation and lipid dysregulation as modifiable drivers of aortic aging. The methylation risk score may eventually enable earlier identification of high-risk individuals before aneurysm formation. Limitations include reliance on blood-based methylation as a proxy for vascular tissue and the fact that this summary is based on the abstract only.
Key Findings
- 1,253 CpG methylation sites associated with AAA; Mendelian randomization supports causal role for 143 of them.
- AP-1 and NF-κB inflammatory transcription factor programs dominate the epigenetic architecture of AAA risk.
- Blood lipids mediate >40% of methylation-associated AAA risk near cholesterol genes LDLR and TRIB1.
- Circulating MMP9, MMP13, IL1RN, DAG1, and NEXN identified as inflammation-related causal intermediates.
- A DNA methylation risk score predicted AAA beyond standard clinical risk factors in two external validation cohorts.
Methodology
Epigenome-wide association study of 1,324 incident AAA cases and 42,065 controls drawn from the VA Million Veteran Program. Mendelian randomization, expression quantitative trait methylation, multi-trait colocalization, and network Mendelian randomization were applied to strengthen causal inference and pathway mapping. A methylation risk score was derived via penalized regression and externally validated in two independent cohorts.
Study Limitations
Blood-derived methylation may not fully reflect epigenetic changes occurring directly in aortic tissue. The cohort is predominantly male veterans, which may limit generalizability. This summary is based on the abstract only, as the full text was not available.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: